Unknown

Dataset Information

Role of Genetic Variations in CDK2, CCNE1 and p27KIP1 in Prostate Cancer.


ABSTRACT:

Background/aim

Our aim was to investigate possible influences of genetic variants in genes involved in the G1/S transition [cyclin-dependent kinase-2 (CDK2), cyclin E1 (CCNE1) and cyclin-dependent kinase inhibitor 1B (p27KIP1)] on the expression/activity of their corresponding proteins and to assess the functional impact of these variants on the risk of prostate cancer.

Materials and methods

We genotyped 530 cases and 562 healthy controls for two relevant single nucleotide polymorphisms (CDK2 rs2069408 and CCNE1 rs997669) by TaqMan genotyping assay. p27KIP1 rs2066827 polymorphisms were studied by polymerase chain reaction-restriction fragment length polymorphism assay. In addition, the expression of CDK2, CCNE1 and p27KIP1 was eval

SUBMITTER: Hives M 

PROVIDER: S-EPMC9016479 | biostudies-literature | 2022 May-Jun

REPOSITORIES: biostudies-literature